The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Interleukin-17 causes Rho-kinase-mediated endothelial dysfunction and hypertension
Open accessAbstract
AIMS: Elevated levels of pro-inflammatory cytokine interleukin-17A (IL-17) are associated with hypertensive autoimmune diseases; however, the connection between IL-17 and hypertension is unknown. We hypothesized that IL-17 increases blood pressure by decreasing endothelial nitric oxide production. METHODS AND RESULTS: Acute treatment of endothelial cells with IL-17 caused a significant increase in phosphorylation of the inhibitory endothelial nitric oxide (NO) synthase residue threonine 495 (eNOS Thr495). Of the kinases known to phosphorylate eNOS Thr495, only inhibition of Rho-kinase prevented the IL-17-induced increase. IL-17 caused a threefold increase in the Rho-kinase activator RhoA, and this was prevented by an IL-17 neutralizing antibody. In isolated mouse aortas, IL-17 significantly increased eNOS Thr495 phosphorylation, induced RhoA expression, and decreased NO-dependent relaxation responses, all of which were prevented by either an IL-17 neutralizing antibody or inhibition of Rho-kinase. In mice, IL-17 treatment for 1 week significantly increased systolic blood pressure and this was associated with decreased aortic NO-dependent relaxation responses, increased eNOS Thr495 phosphorylation, and increased RhoA expression. Inhibition of Rho-kinase prevented the hypertension caused by IL-17. CONCLUSION: These data demonstrate that IL-17 activates RhoA/Rho-kinase leading to endothelial dysfunction and hypertension. Inhibitors of IL-17 or Rho-kinase may prove useful as anti-hypertensive drugs in IL-17-associated autoimmune diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of the T cell in the genesis of angiotensin II–induced hypertension and vascular dysfunction
Guzik, T. J., Hoch, N. E., Brown, K. A., McCann, L. A., Rahman, A., Dikalov, S., Goronzy, J., Weyand, C., & Harrison, D. G. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070657 · Cited by 1,736
Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease
Onishi, R. M., & Gaffen, S. L. (2010) · Immunology · doi:10.1111/j.1365-2567.2009.03240.x · Cited by 894
Inflammation, Immunity, and Hypertension
Harrison, D. G., Guzik, T. J., Lob, H. E., Madhur, M. S., Marvar, P. J., Thabet, S. R., Vinh, A., & Weyand, C. M. (2011) · Hypertension · doi:10.1161/hypertensionaha.110.163576 · Cited by 871
Interleukin 17 Promotes Angiotensin II–Induced Hypertension and Vascular Dysfunction
Madhur, M. S., Lob, H. E., McCann, L. A., Iwakura, Y., Blinder, Y., Guzik, T. J., & Harrison, D. G. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.145094 · Cited by 827
Fleming, I., Fisslthaler, B., Dimmeler, S., Kemp, B. E., & Busse, R. (2001) · Circulation Research · doi:10.1161/hh1101.092677 · Cited by 770
Bautista, L. E., Vera, L. M., Arenas, I. A., & Gamarra, G. (2005) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001785 · Cited by 568
Wong, C. K., Lit, L. C. W., Tam, L. S., Li, E. K. M., Wong, P. T. Y., & Lam, C. W. K. (2008) · Clinical Immunology · doi:10.1016/j.clim.2008.01.019 · Cited by 532
Cellular mechanisms of IL-17-induced blood-brain barrier disruption
Huppert, J., Closhen, D., Croxford, A., White, R., Kulig, P., Pietrowski, E., Bechmann, I., Becher, B., Luhmann, H. J., Waisman, A., et al. (2010) · The FASEB Journal · doi:10.1096/fj.09-141978 · Cited by 529
Regulation of endothelial and myocardial NO synthesis by multi-site eNOS phosphorylation
Mount, P. F., Kemp, B. E., & Power, D. A. (2007) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2006.05.023 · Cited by 498
Fulton, D., Gratton, J.-P., & Sessa, W. C. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29198-9 · Cited by 495
Wong, C. K., Ho, C. Y., Li, E., & Lam, C. (2000) · Lupus · doi:10.1191/096120300678828703 · Cited by 472
Santner-Nanan, B., Peek, M. J., Khanam, R., Richarts, L., Zhu, E., Fazekas de St Groth, B., & Nanan, R. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901154 · Cited by 469
Chabaud, M., Fossiez, F., Taupin, J.-L., & Miossec, P. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.1.409 · Cited by 457
An overview of IL-17 function and signaling
Gaffen, S. L. (2008) · Cytokine · doi:10.1016/j.cyto.2008.07.017 · Cited by 382
Starnes, T., Robertson, M. J., Sledge, G., Kelich, S., Nakshatri, H., Broxmeyer, H. E., & Hromas, R. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.8.4137 · Cited by 349
Marvar, P. J., Thabet, S. R., Guzik, T. J., Lob, H. E., McCann, L. A., Weyand, C., Gordon, F. J., & Harrison, D. G. (2010) · Circulation Research · doi:10.1161/circresaha.110.217299 · Cited by 317
The Role of IL-23/IL-17 Axis in Lupus Nephritis
Zhang, Z., Kyttaris, V. C., & Tsokos, G. C. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900385 · Cited by 303
Antonysamy, M. A., Fanslow, W. C., Fu, F., Li, W., Qian, S., Troutt, A. B., & Thomson, A. W. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.1.577 · Cited by 293
Roussel, L., Houle, F., Chan, C., Yao, Y., Bérubé, J., Olivenstein, R., Martin, J. G., Huot, J., Hamid, Q., Ferri, L., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903162 · Cited by 272
Huang, H., Kim, H. J., Chang, E.-J., Lee, Z. H., Hwang, S. J., Kim, H.-M., Lee, Y., & Kim, H.-H. (2009) · Cell Death & Differentiation · doi:10.1038/cdd.2009.74 · Cited by 272
Lin, M. I., Fulton, D., Babbitt, R., Fleming, I., Busse, R., Pritchard, K. A., & Sessa, W. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302836200 · Cited by 236
Hata, K., Andoh, A., Shimada, M., Fujino, S., Bamba, S., Araki, Y., Okuno, T., Fujiyama, Y., & Bamba, T. (2002) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00494.2001 · Cited by 218
IL-6 Deficiency Protects Against Angiotensin II–Induced Endothelial Dysfunction and Hypertrophy
Schrader, L. I., Kinzenbaw, D. A., Johnson, A. W., Faraci, F. M., & Didion, S. P. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.153080 · Cited by 184
Turcotte, S., Desrosiers, R. R., & Béliveau, R. (2003) · Journal of Cell Science · doi:10.1242/jcs.00427 · Cited by 163
Novel Rho Kinase Inhibitors with Anti-inflammatory and Vasodilatory Activities
Doe, C. P., Bentley, R. G., Behm, D. J., Lafferty, R., Stavenger, R. A., Jung, D. K., Bamford, M. J., Panchal, T. A., Grygielko, E. T., Wright, L. L., et al. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.110635 · Cited by 161
Gaffen, S. L., Kramer, J. M., Yu, J. J., & Shen, F. (2006) · Vitamins and hormones · doi:10.1016/s0083-6729(06)74010-9 · Cited by 152
Hyperhomocystinemia Impairs Endothelial Function and eNOS Activity via PKC Activation
Jiang, X., Yang, F., Tan, H., Liao, D., Bryan, R. M., Randhawa, J. K., Rumbaut, R. E., Durante, W., Schafer, A. I., Yang, X., et al. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000189559.87328.e4 · Cited by 144
Transforming growth factor-β1 regulates macrophage migration via RhoA
Kim, J.-S., Kim, J.-G., Moon, M.-Y., Jeon, C.-Y., Won, H.-Y., Kim, H.-J., Jeon, Y.-J., Seo, J.-Y., Kim, J.-I., Kim, J., et al. (2006) · Blood · doi:10.1182/blood-2005-10-009191 · Cited by 134
Human endothelial cells generate Th17 and regulatory T cells under inflammatory conditions
Taflin, C., Favier, B., Baudhuin, J., Savenay, A., Hémon, P., Bensussan, A., Charron, D. J., Glotz, D., & Mooney, N. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011811108 · Cited by 118
TLR Signals Promote IL-6/IL-17-Dependent Transplant Rejection
Chen, L., Bugeaud, E., Wang, T., Wang, Y., Ochando, J., Chong, A. S., & Alegre, M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803842 · Cited by 110
T lymphocytes: a role in hypertension?
Schiffrin, E. L. (2010) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e3283360a2e · Cited by 110
IL-17 in Systemic Lupus Erythematosus
Crispín, J. C., & Tsokos, G. C. (2010) · BioMed Research International · doi:10.1155/2010/943254 · Cited by 108
Orshal, J. M., & Khalil, R. A. (2004) · Hypertension · doi:10.1161/01.hyp.0000113044.46326.98 · Cited by 98
Mechanisms of Soluble β-Amyloid Impairment of Endothelial Function
Gentile, M. T., Vecchione, C., Maffei, A., Aretini, A., Marino, G., Poulet, R., Capobianco, L., Selvetella, G., & Lembo, G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407358200 · Cited by 95
Is hypertension an immunologic disease?
Harrison, D. G., Guzik, T. J., Goronzy, J. J., & Weyand, C. M. (2008) · Current Cardiology Reports · doi:10.1007/s11886-008-0073-6 · Cited by 77
Wang, S., Liang, B., Viollet, B., & Zou, M. (2011) · Hypertension · doi:10.1161/hypertensionaha.110.168906 · Cited by 76
A pathogenic role of IL- 17 at the early stage of corneal allograft rejection
Chen, H., Wang, W., Xie, H., Xu, X., Wu, J., Jiang, Z., Zhang, M., Zhou, L., & Zheng, S. (2009) · Transplant Immunology · doi:10.1016/j.trim.2009.03.006 · Cited by 75
Chiasson, V. L., Talreja, D., Young, K. J., Chatterjee, P., Banes‐Berceli, A. K. L., & Mitchell, B. M. (2011) · Hypertension · doi:10.1161/hypertensionaha.110.162917 · Cited by 74
Self-citationIL-17 Contributes to the Development of Chronic Rejection in a Murine Heart Transplant Model
Itoh, S., Nakae, S., Axtell, R. C., Velotta, J. B., Kimura, N., Kajiwara, N., Iwakura, Y., Saito, H., Adachi, H., Steinman, L., et al. (2010) · Journal of Clinical Immunology · doi:10.1007/s10875-009-9366-9 · Cited by 66
Davis, J. R., Giardina, J. B., Green, G. M., et al. (2002) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00270.2001 · Cited by 63
Gu, J., Tian, N., Shparago, M., Tan, W. H., Bailey, A. P., & Manning, R. D. (2006) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00153.2006 · Cited by 60
Long, C., Cook, L. G., Hamilton, S. L., Wu, G., & Mitchell, B. M. (2007) · Hypertension · doi:10.1161/01.hyp.0000257914.80918.72 · Cited by 57
Self-citationTGF-β, IL-6, IL-17 and CTGF direct multiple pathologies of chronic cardiac allograft rejection
Booth, A. J., & Bishop, D. K. (2010) · Immunotherapy · doi:10.2217/imt.10.33 · Cited by 53
Cook, L. G., Chiasson, V. L., Long, C., Wu, G., & Mitchell, B. M. (2009) · Kidney International · doi:10.1038/ki.2008.697 · Cited by 49
Self-citationLong, C., Cook, L. G., Wu, G., & Mitchell, B. M. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.144808 · Cited by 49
Self-citationRho kinase contributes to basal vascular tone in humans: role of endothelium-derived nitric oxide
Büssemaker, E., Pistrosch, F., Förster, S., Herbrig, K., Gross, P. A., Passauer, J., & Brandes, R. P. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00770.2006 · Cited by 46
Versteilen, A. M. G., Korstjens, I. J. M., Musters, R. J. P., Groeneveld, A. B. J., & Sipkema, P. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00434.2005 · Cited by 43
Synergistic effects of vascular IL-17 and TNF$alpha; may promote coronary artery disease
Csiszár, A., & Ungvari, Z. I. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2004.03.009 · Cited by 41
Marshall, A. K., Barrett, O. P. T., Cullingford, T. E., Shanmugasundram, A., Sugden, P. H., & Clerk, A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010027 · Cited by 39
In vivoeffects of interleukin‐17 on haematopoietic cells and cytokine release in normal mice
Jovčić, G., Bugarski, D. S., Petakov, M., Krstić, J., Vlaski‐Lafarge, M., Stojanovic, N., & Milenković, P. (2004) · Cell Proliferation · doi:10.1111/j.1365-2184.2004.00322.x · Cited by 32
Liang, J., Zheng, Z., Wang, M., Han, L., Zheng, Z., Peng, J., LIU, Z., & Wei, Y. (2009) · Journal of International Medical Research · doi:10.1177/147323000903700331 · Cited by 28
Association analysis of polymorphisms at the interleukin‐1 locus in essential hypertension
Lin, R. C. Y., & Morris, B. J. (2001) · American Journal of Medical Genetics · doi:10.1002/ajmg.10177 · Cited by 24
Effect of interleukin-17 on hematopoietic cells and cytokine release in mouse spleen
Jovčić, G., Bugarski, D. S., Krstić, J., Vlaski‐Lafarge, M., Petakov, M., Mojsilović, S. B., Stojanovic, N., & Milenković, P. (2007) · Physiological Research · doi:10.33549/physiolres.930944 · Cited by 20
Effect of fasudil on macrovascular disorder-induced endothelial dysfunction
Shah, D. I., & Singh, M. (2006) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y06-036 · Cited by 15
Cited by
Endothelial dysfunction and vascular disease - a 30th anniversary update
Vanhoutte, P. M., Shimokawa, H., Feletou, M., & Tang, E. H. C. (2017) · Acta Physiologica · doi:10.1111/apha.12646 · Cited by 937
“…deletion of collectrin (homolog of ACE2; Cechova et al. 2013); (iv) increase in the Rho-kinase activator RhoA (by administration of interleukin-17A; Nguyen et al. 2013); (v) deletion of a-CGRP (Smillie et al. 2014); (vi) deletion of small GTPase Ras-related protein 1 (Rap1b; Lakshmikanthan et al.…”
BackgroundRoles of Inflammation, Oxidative Stress, and Vascular Dysfunction in Hypertension
Dinh, Q. N., Drummond, G. R., Sobey, C. G., & Chrissobolis, S. (2014) · BioMed Research International · doi:10.1155/2014/406960 · Cited by 598
DC isoketal-modified proteins activate T cells and promote hypertension
Kirabo, A., Fontana, V., de Faria, A. P. C., Loperena, R., Galindo, C. L., Wu, J., Bikineyeva, A. T., Dikalov, S., Xiao, L., Chen, W., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74084 · Cited by 538
The role of infiltrating immune cells in dysfunctional adipose tissue
Guzik, T. J., Skiba, D. S., Touyz, R. M., & Harrison, D. G. (2017) · Cardiovascular Research · doi:10.1093/cvr/cvx108 · Cited by 445
Shah, D. A., & Khalil, R. A. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.04.012 · Cited by 422
Metadata
- Authors
- Nguyen, H., Chiasson, V. L., Chatterjee, P., Kopriva, S. E., Young, K. J., & Mitchell, B. M.
- Venue
- Cardiovascular Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-12-21
- Volume
- 97
- Issue
- 4
- Pages
- 696-704
- ISSN
- 0008-6363 (ISSN-L)
- 1755-3245
- OpenAlex
- W2167750356
- Cited by
- 300
- References
- 54
- FWCI
- 6.42
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.